CONTACT: LINDSAY RUNYAN
Release: June 17,
Iowa City IA 52242
(319) 335-9585; fax (319) 384-4638
Note to Editors: This release originally was distributed April 25, 2002.
People are still welcome to participate in the study.
People with OCD invited to participate in UI study
People with obsessive compulsive disorder (OCD) are invited to participate
in a University of Iowa Health Care treatment study. The study will examine
the effectiveness of a new medication to treat OCD. Some participants will
receive a placebo (inactive medication).
Participants must be between the ages of 18 and 65 and cannot be abusing
alcohol or drugs. Participants must be able to remain free of any prescription
or nonprescription psychotropic drugs for two weeks, give prior consent to
participate and sign an informed consent. Women must not be pregnant or planning
to get pregnant during the study period. The study will consist of a two-
to four- week, single-blind, placebo screening period, 12 weeks of double-blind
treatment, followed by one week of placebo washout. The first visit includes
a physical examination. The follow-up visits involve assessment of the participant's
disorder as well as discussion of the medication and its side effects.
For more information, contact the study's lead investigator, Donald W. Black,
M.D., UI professor of psychiatry, at (319) 353-4431.
University of Iowa Health Care describes the partnership between the
UI Roy J. and Lucille A. Carver College of Medicine and the UI Hospitals and
Clinics and the patient care, medical education and research programs and
services they provide. Visit UI Health Care online at www.uihealthcare.com.